ISSN：1001-7143　CN：11-2684/G3 ENGLISH

中国科技期刊研究 ›› 2022, Vol. 33 ›› Issue (4): 521-528. doi: 10.11946/cjstp.202201300070

• 评论与分析 • 上一篇    下一篇

《中华医学杂志(英文版)》与国外医学会会刊的引证指标特征分析与发展建议

吕鹏1,2),†()(), 王越3),†()(), 王宁宁2,4), 尤嘉琮2,5), 刘谦2,6), 郝秀原2,7), 刘冰2,8), 魏均民2,8),*()()   

  1. 1)中华医学会杂志社《癌症发生与治疗(英文)》编辑部,北京市西城区宣武门东河沿街69号 100052
    2)医学期刊知识挖掘与服务重点实验室,北京市西城区宣武门东河沿街69号 100052
    3)中国食品药品检定研究院,北京市大兴区华佗路31号 102629
    4)中华医学会杂志社《门脉高压与肝硬化(英文)》编辑部,北京市西城区宣武门东河沿街69号 100052
    5)中华医学会杂志社《风湿病与自身免疫(英文)》编辑部,北京市西城区宣武门东河沿街69号 100052
    6)中华医学会杂志社期刊发展部,北京市西城区宣武门东河沿街69号 100052
    7)中华医学会杂志社《中华医学杂志(英文版)》编辑部,北京市西城区宣武门东河沿街69号 100052
    8)中华医学会杂志社,北京市西城区宣武门东河沿街69号 100052
  • 收稿日期:2022-01-30 修回日期:2022-03-03 出版日期:2022-04-15 发布日期:2022-05-23
  • 通讯作者: 魏均民 E-mail:lvpeng@cmaph.org;wangyue@nifdc.org.cn;weijunmin@cmaph.org
  • 作者简介:吕 鹏(ORCID:0000-0002-7357-3227),博士,副编审,E-mail: lvpeng@cmaph.org;
    王 越(ORCID:0000-0002-1408-9208),硕士,副主任药师,E-mail: wangyue@nifdc.org.cn;
    王宁宁,硕士,编辑;
    尤嘉琮,博士,副编审;
    刘 谦,硕士,编审;
    郝秀原,博士,编审;
    刘 冰,硕士,编审
    第一联系人： 为共同第一作者。
  • 基金资助:
    2021年中国科技期刊卓越行动计划高起点新刊项目(2021-001)

Citation indices between Chinese Medical Journal and foreign medical association journals: Comparative analysis and development suggestions

LYU Peng1,2),†()(), WANG Yue3),†()(), WANG Ningning2,4), YOU Jiacong2,5), LIU Qian2,6), HAO Xiuyuan2,7), LIU Bing2,8), WEI Junmin2,8),*()()   

  1. 1) Editorial Office of Cancer Pathogenesis & Therapy, Chinese Medical Association Publishing House, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
    2) Key Laboratory of Knowledge Mining and Service for Medical Journals, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
    3) National Institutes for Food and Drug Control, 31 Huatuo Road, Daxing District, Beijing 102629, China
    4) Editorial Office of Portal Hypertension & Cirrhosis, Chinese Medical Association Publishing House, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
    5) Editorial Office of Rheumatology & Autoimmunity, Chinese Medical Association Publishing House, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
    6) Department of Journal Development, Chinese Medical Association Publishing House, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
    7) Editorial Office of Chinese Medical Journal, Chinese Medical Association Publishing House, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
    8) Chinese Medical Association Publishing House, 69 Dongheyan Street, Xuanwumen, Xicheng District, Beijing 100052, China
  • Received:2022-01-30 Revised:2022-03-03 Online:2022-04-15 Published:2022-05-23
  • Contact: WEI Junmin E-mail:lvpeng@cmaph.org;wangyue@nifdc.org.cn;weijunmin@cmaph.org

RichHTML

PDF

摘要：

【目的】 通过《中华医学杂志(英文版)》(Chinese Medical Journal, CMJ;中华医学会会刊)对标《美国医学会杂志》(Journal of the American Medical Association, JAMA;美国医学会会刊)、《加拿大医学会杂志》(Canadian Medical Association Journal, CMAJ;加拿大医学会会刊)、《英国医学杂志》(British Medical Journal, BMJ;英国医学会会刊),探讨缩小CMJ与其他国家医学会会刊差距的对策与措施,为我国一流科技期刊的建设提供参考和借鉴。【方法】 利用Web of Science 数据库和期刊官网,检索并总结四国医学会会刊的各项指标数据,如影响因子、发文量、总被引频次、期刊引文指标(Journal Citation Indicator,JCI)、辐射范围、作者分布以及尖端论文等。【结果】 CMJ的主要引证指标与JAMA、CMAJ、BMJ相比,除发文量外,其他数据差距明显。2016—2020年4种期刊的发文量分别为1590篇、1032篇、458篇和927篇。CMJ的发文量优势明显,分别为对标期刊的1.54倍、3.47倍和1.72倍。2020年4种期刊的总被引频次分别为34344次、687922次、64437次和600100次,即使总被引频次相对较少的CMAJ,其总被引频次也为CMJ的1.88倍。CMJ本国作者的发文比例为91.216%,明显高于JAMA、CMAJ和BMJ的本国作者发文比例(72.407%、76.539%和59.646%)。另外,CMJ的近5年的JCI均小于1,而JAMA、CMAJ和BMJ的JCI分别为11.49,1.84和6.27。【结论】 我国科技期刊可通过期刊高质量建设战略,追踪研究热点与重大事件,引领学科发展,同时构建期刊学术生态圈,从而提升期刊的国际传播力与影响力。坚信在相关国家政策的支持下不断调整办刊思路,我国科技期刊一定会实现从跟跑,齐平到超越的伟大迈进。

关键词: 中国科技期刊卓越行动计划, 领军期刊, 《中华医学杂志(英文版)》, 《美国医学会杂志》, 《加拿大医学会杂志》, 《英国医学杂志》

Abstract:

[Purposes] This paper aims to explore the measures to narrow the gap between Chinese Medical Journal (CMJ) and three medical association journals, i.e., Journal of the American Medical Association (JAMA), Canadian Medical Association Journal (CMAJ), and British Medical Journal (BMJ). [Methods] Through searching the Journal Citation Reports (JCR) in the Web of Science database and journal websites, we summarized the index data of the four journals, such as impact factor, volume of articles, total cites, journal citation indicator (JCI), coverage, author distribution, and top papers. [Findings] There was a significant difference in citation indices between CMJ and JAMA, CMAJ, and BMJ, except for the volume of articles. From 2016 to 2020, the volume of articles in the four journals was 1590, 1032, 458, and 927, respectively. CMJ has obvious advantages in the volume of articles, which is 1.54, 3.47, and 1.72 times that of the benchmark journals, respectively. The total cites of the four journals in 2020 were 34344, 687922, 64437, and 600100, respectively, and even CMAJ with a lower total cites was 1.88 times higher than CMJ. The proportion of articles published by domestic authors was 91.216% for CMJ, which is significantly higher than that of JAMA (72.407%), CMAJ (76.539%), and BMJ (59.646%). In addition, the JCI in recent 5 years was less than 1 for CMJ, while it was 11.49, 1.84, and 6.27 for JAMA, CMAJ, and BMJ, respectively. [Conclusions] By tracking hot spots and major events, CMJ is expected to lead the development of disciplines and construct the academic ecology of publications through the strategy of high-quality construction of publications. Furthermore, the international outreach and influence of Chinese scientific journals can be enhanced. By constantly adjusting the publication idea, we will surely achieve great progress from following to surpassing under the support of national policies.

Key words: Excellence Action Plan for China STM Journals, Leading journal, Chinese Medical Journal, Journal of the American Medical Association, Canadian Medical Association Journal, British Medical Journal

联系我们

地址：北京市海淀区北四环西路33号中国科学院文献情报中心731室
邮编：100190
电话：010-62572403
E-mail：cjstp@mail.las.ac.cn
微信公众号
cas_cjstp
版权所有 © 《中国科技期刊研究》编辑部
总访问量 　今日访问 　在线人数